Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

"Connections with Evan Dawson" brings you special rebroadcasts on 1/30/25. First, AI expert Landon Gray on the future of ...

In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare diseases, the unique challenges faced by pharmaceutical companies, healthcare ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...

The future of glaucoma research holds tremendous potential for improving diagnosis, treatment, and patient outcomes. It is AI, gene therapy and stem cell which are revolutionizing glaucoma care by ...

New gene editing methods have been introduced in the country, bringing new hope to couples who tested positive for certain ...

GenScript Biotech, a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies announced the successful conclusion of its 2025 JPM Global Forum held ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

Precision medicine is a kind of personalized cancer care treatment where every cancer patient is treated differently.